Regulatory Affairs for Pharmaceutical Support Staff: Overview of EU Regulatory (Regulations, Directives and Guidelines) Procedures - London, United Kingdom - September 23-24, 2019
DUBLIN, June 6, 2019 /PRNewswire/ -- The "Regulatory Affairs for Support Staff" conference has been added to ResearchAndMarkets.com's offering.
This two-day course provides an introduction to pharmaceutical regulatory affairs and the basics of drug development and has been designed specifically for those working in a support staff role.
By attending this course you will gain an overview of EU regulatory procedures required to register products in Europe and the regulatory activities that need to be complied with to keep products on the market. Pharmacovigilance and safety reporting will be covered as well as licence variations and the commercial aspects of pharmaceutical products. The potential impact of Brexit will also be discussed. The course will provide a thorough grounding in the subject of regulatory affairs and enable you to perform in your role more effectively.
Benefits of attending:
- Understand the background of EU law - regulations, directives and guidelines
- Consider the potential impact of Brexit
- Assess the impact of the EU Clinical Trial Regulation
- Gain an understanding of the Common Technical Document n Discuss how to apply for a marketing authorisation in the EU - the centralised, decentralised and mutual recognition procedures
- Clarify post-authorisation obligations - pharmacovigilance, variations and renewals
Who Should Attend:
This course is specifically designed for anyone working in regulatory affairs including personal assistants, secretaries, administrators and any member of support staff wishing to gain a greater understanding of regulatory affairs in the pharmaceutical industry. It is also suitable for those who interface with the regulatory affairs function and who provide support to the regulatory procedures and activities.
Agenda:
Programme - Day one
European Law - Regulations, Directives
- Impact of Brexit
Where can we find the information on regulatory affairs, approvals, withdrawal?
- The Internet/publications
- Approvals and withdrawals
The drug development process
- Drug discovery
- Pharmaceutical R&D
- Non-clinical tests
- Clinical studies - Phase I to IV
- Registration
CASE STUDY 1
- The EU Clinical Trials Directive and new Clinical Trial Regulation*
- What is the process for running clinical trials in Europe?
Seeking scientific advice in Europe
- What are the processes?
The Common Technical Document
- Structure and content of a CTD
The European Medicines Agency
- Impact of Brexit
Impact of Brexit
Programme - Day two
Applying for a Marketing Authorisation in the EU with discussion on the impact of Brexit
- The EU centralised procedure
- Decentralised procedure
- Mutual recognition procedure
- National procedures
CASE STUDY 2
Generic applications
- Requirements
Parallel trade
- How the process works
- Impact of Bexit
Managing product labelling
- Company core data sheets
- Updates to Summary of Product Characteristics
Post-authorisation obligations; pharmacovigilance, variations and renewals including discussion on the impact of Brexit
Pharmacovigilance and GCP inspections
Licence variations
- Type I and Type II variations
- Procedures and timelines
CASE STUDY 3
Renewals
Managing and supporting a regulatory affairs department
- Things to consider
- Maintaining oversight
Programme - Day two
Applying for a Marketing Authorisation in the EU with discussion on the impact of Brexit
- The EU centralised procedure
- Decentralised procedure
- Mutual recognition procedure
- National procedures
CASE STUDY 2
Generic applications
- Requirements
Parallel trade
- How the process works
- Impact of Bexit
Managing product labelling
- Company core data sheets
- Updates to Summary of Product Characteristics
Post-authorisation obligations; pharmacovigilance, variations and renewals including discussion on the impact of Brexit
Pharmacovigilance and GCP inspections
Licence variations
- Type I and Type II variations
- Procedures and timelines
CASE STUDY 3
Renewals
Managing and supporting a regulatory affairs department
- Things to consider
- Maintaining oversight
Speakers:
Norah Lightowler
Management Forum
Norah Lightowler is a partner in Lightowler Associates, an independent consultancy offering regulatory advice and support to pharmaceutical companies in or proposing to enter the European market for human pharmaceuticals. They are in their twentieth year of successful business.
Norah has wide experience in the pharmaceutical and related neutraceutical, herbal and devices industries as a pharmaceutical assessor with the UK regulatory authority and as associate director of European regulatory affairs with an international pharmaceutical company. She is experienced in organising and presenting courses on European regulatory control systems, including requirements, procedures and strategy.
For more information about this conference visit https://www.researchandmarkets.com/r/pex1h0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article